Skip to main content
Top
Published in: Digestive Diseases and Sciences 1/2020

01-01-2020 | Helminths | UNM CLINICAL CASE CONFERENCES

As the Worm Turns: A Globally Prevalent Cause of Chronic Diarrhea

Authors: Swathi Paleti, Jawairia Memon, Chinemerem Okwara, Joshua Hanson, Denis McCarthy

Published in: Digestive Diseases and Sciences | Issue 1/2020

Login to get access

Excerpt

A 54-year-old male was evaluated in the outpatient clinic for the complaint of chronic diarrhea. His past medical history included Helicobacter pylori infection, which was treated with triple therapy by his primary care physician, with eradication confirmed. He had no surgical history. The patient reported that he had been having about 2-3 loose bowel movements per day for 1 year; prior to that, he had had 1 solid bowel movement per day. The diarrhea was associated with intermittent, generalized abdominal discomfort that improved after a bowel movement. He also complained of abdominal bloating and excessive flatulence. He had migrated to the USA from Vietnam 5 months previously, although his symptoms had started I year previously while he was still in Vietnam. His wife was experiencing similar symptoms. Social and family histories were unremarkable. He was not using any medications including NSAIDs. His vital signs were normal on admission, and physical examination was unremarkable, including that of the abdomen. …
Literature
1.
go back to reference Genta RM. Global prevalence of strongyloidiasis: critical review with epidemiologic insights into the prevention of disseminated disease. Rev Infect Dis. 1989;11(5):755–767.CrossRef Genta RM. Global prevalence of strongyloidiasis: critical review with epidemiologic insights into the prevention of disseminated disease. Rev Infect Dis. 1989;11(5):755–767.CrossRef
2.
go back to reference Liu LX, Weller PF. Strongyloidiasis and other intestinal nematode infections. Infect Dis Clin North Am. 1993;7(3):655–682.PubMed Liu LX, Weller PF. Strongyloidiasis and other intestinal nematode infections. Infect Dis Clin North Am. 1993;7(3):655–682.PubMed
3.
go back to reference Olsen A, et al. Strongyloidiasis–the most neglected of the neglected tropical diseases? Trans R Soc Trop Med Hyg. 2009;103(10):967–972.CrossRef Olsen A, et al. Strongyloidiasis–the most neglected of the neglected tropical diseases? Trans R Soc Trop Med Hyg. 2009;103(10):967–972.CrossRef
4.
go back to reference Concha R, Harrington W Jr, Rogers AI. Intestinal strongyloidiasis: recognition, management, and determinants of outcome. J Clin Gastroenterol. 2005;39(3):203–211.CrossRef Concha R, Harrington W Jr, Rogers AI. Intestinal strongyloidiasis: recognition, management, and determinants of outcome. J Clin Gastroenterol. 2005;39(3):203–211.CrossRef
5.
go back to reference Mark Feldman, L.S.F.M.H.S., Sleisenger & Fordtran's gastrointestinal and liver disease: pathophysiology, diagnosis, management. 2002, Seventh edition. Philadelphia: Saunders, [2002] ©2002. p. 1972. Mark Feldman, L.S.F.M.H.S., Sleisenger & Fordtran's gastrointestinal and liver disease: pathophysiology, diagnosis, management. 2002, Seventh edition. Philadelphia: Saunders, [2002] ©2002. p. 1972.
6.
go back to reference Ganesh S, Cruz RJ Jr. Strongyloidiasis: a multifaceted disease. Gastroenterol Hepatol (N Y). 2011;7(3):194–196. Ganesh S, Cruz RJ Jr. Strongyloidiasis: a multifaceted disease. Gastroenterol Hepatol (N Y). 2011;7(3):194–196.
7.
go back to reference Fardet L, et al. Severe strongyloidiasis in corticosteroid-treated patients: case series and literature review. J Infect. 2007;54(1):18–27.CrossRef Fardet L, et al. Severe strongyloidiasis in corticosteroid-treated patients: case series and literature review. J Infect. 2007;54(1):18–27.CrossRef
8.
go back to reference Schaeffer MW, et al. Strongyloides hyperinfection syndrome after heart transplantation: case report and review of the literature. J Heart Lung Transplant. 2004;23(7):905–911.CrossRef Schaeffer MW, et al. Strongyloides hyperinfection syndrome after heart transplantation: case report and review of the literature. J Heart Lung Transplant. 2004;23(7):905–911.CrossRef
9.
go back to reference Porto AF, et al. HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis. Parasite Immunol. 2001;23(9):503–507.CrossRef Porto AF, et al. HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis. Parasite Immunol. 2001;23(9):503–507.CrossRef
10.
go back to reference Keiser PB, Nutman TB. Strongyloides stercoralis in the Immunocompromised Population. Clin Microbiol Rev. 2004;17(1):208–217.CrossRef Keiser PB, Nutman TB. Strongyloides stercoralis in the Immunocompromised Population. Clin Microbiol Rev. 2004;17(1):208–217.CrossRef
11.
go back to reference Pirisi M, et al. Unsuspected strongyloidiasis in hospitalised elderly patients with and without eosinophilia. Clin Microbiol Infect. 2006;12(8):787–792.CrossRef Pirisi M, et al. Unsuspected strongyloidiasis in hospitalised elderly patients with and without eosinophilia. Clin Microbiol Infect. 2006;12(8):787–792.CrossRef
12.
go back to reference Kassalik M, Monkemuller K. Strongyloides stercoralis hyperinfection syndrome and disseminated disease. Gastroenterol Hepatol (N Y). 2011;7(11):766–768. Kassalik M, Monkemuller K. Strongyloides stercoralis hyperinfection syndrome and disseminated disease. Gastroenterol Hepatol (N Y). 2011;7(11):766–768.
13.
go back to reference Roxby AC, Gottlieb GS, Limaye AP. Strongyloidiasis in transplant patients. Clin Infect Dis. 2009;49(9):1411–1423.CrossRef Roxby AC, Gottlieb GS, Limaye AP. Strongyloidiasis in transplant patients. Clin Infect Dis. 2009;49(9):1411–1423.CrossRef
14.
go back to reference Boulware DR, et al. Maltreatment of Strongyloides infection: case series and worldwide physicians-in-training survey. Am J Med. 2007;120(6):545.e1–545.e8.CrossRef Boulware DR, et al. Maltreatment of Strongyloides infection: case series and worldwide physicians-in-training survey. Am J Med. 2007;120(6):545.e1–545.e8.CrossRef
15.
go back to reference Gill GV, et al. Chronic Strongyloides stercoralis infection in former British Far East prisoners of war. Qjm. 2004;97(12):789–795.CrossRef Gill GV, et al. Chronic Strongyloides stercoralis infection in former British Far East prisoners of war. Qjm. 2004;97(12):789–795.CrossRef
16.
go back to reference Roman-Sanchez P, et al. High prevalence of Strongyloides stercoralis among farm workers on the Mediterranean coast of Spain: analysis of the predictive factors of infection in developed countries. Am J Trop Med Hyg. 2003;69(3):336–340.CrossRef Roman-Sanchez P, et al. High prevalence of Strongyloides stercoralis among farm workers on the Mediterranean coast of Spain: analysis of the predictive factors of infection in developed countries. Am J Trop Med Hyg. 2003;69(3):336–340.CrossRef
17.
go back to reference Vadlamudi RS, Chi DS, Krishnaswamy G. Intestinal strongyloidiasis and hyperinfection syndrome. Clin Mol Allergy. 2006;4:8.CrossRef Vadlamudi RS, Chi DS, Krishnaswamy G. Intestinal strongyloidiasis and hyperinfection syndrome. Clin Mol Allergy. 2006;4:8.CrossRef
18.
go back to reference Sato Y, et al. Efficacy of stool examination for detection of Strongyloides infection. Am J Trop Med Hyg. 1995;53(3):248–250.CrossRef Sato Y, et al. Efficacy of stool examination for detection of Strongyloides infection. Am J Trop Med Hyg. 1995;53(3):248–250.CrossRef
19.
go back to reference Bailey JW. A serological test for the diagnosis of Strongyloides antibodies in ex Far East Prisoners of War. Ann Trop Med Parasitol. 1989;83(3):241–247.CrossRef Bailey JW. A serological test for the diagnosis of Strongyloides antibodies in ex Far East Prisoners of War. Ann Trop Med Parasitol. 1989;83(3):241–247.CrossRef
20.
go back to reference Uparanukraw P, Phongsri S, Morakote N. Fluctuations of larval excretion in Strongyloides stercoralis infection. Am J Trop Med Hyg. 1999;60(6):967–973.CrossRef Uparanukraw P, Phongsri S, Morakote N. Fluctuations of larval excretion in Strongyloides stercoralis infection. Am J Trop Med Hyg. 1999;60(6):967–973.CrossRef
21.
go back to reference Huaman MC, et al. Gelatin particle indirect agglutination and enzyme-linked immunosorbent assay for diagnosis of strongyloidiasis using Strongyloides venezuelensis antigen. Trans R Soc Trop Med Hyg. 2003;97(5):535–538.CrossRef Huaman MC, et al. Gelatin particle indirect agglutination and enzyme-linked immunosorbent assay for diagnosis of strongyloidiasis using Strongyloides venezuelensis antigen. Trans R Soc Trop Med Hyg. 2003;97(5):535–538.CrossRef
22.
go back to reference Ghasemikhah R, et al. A PCR-Based Molecular Detection of Strongyloides stercoralisin Human Stool Samples from Tabriz City. Iran. Scientia pharmaceutica. 2017;85(2):17.CrossRef Ghasemikhah R, et al. A PCR-Based Molecular Detection of Strongyloides stercoralisin Human Stool Samples from Tabriz City. Iran. Scientia pharmaceutica. 2017;85(2):17.CrossRef
23.
go back to reference Loutfy MR, et al. Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area. Am J Trop Med Hyg. 2002;66(6):749–752.CrossRef Loutfy MR, et al. Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area. Am J Trop Med Hyg. 2002;66(6):749–752.CrossRef
24.
go back to reference Gann PH, Neva FA, Gam AA. A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis. J Infect Dis. 1994;169(5):1076–1079.CrossRef Gann PH, Neva FA, Gam AA. A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis. J Infect Dis. 1994;169(5):1076–1079.CrossRef
Metadata
Title
As the Worm Turns: A Globally Prevalent Cause of Chronic Diarrhea
Authors
Swathi Paleti
Jawairia Memon
Chinemerem Okwara
Joshua Hanson
Denis McCarthy
Publication date
01-01-2020
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 1/2020
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-019-05998-5

Other articles of this Issue 1/2020

Digestive Diseases and Sciences 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.